AnHorn Medicines Presents Research of Novel Protein Degrader for Topical Use at ISID Meeting 2023
/PRNewswire/ -- AnHorn Medicines, a private biotechnology company focused on developing precision medicines for degrading disease-causing proteins, presented...
Source: prnewswire.com